OpenFilings
BridgeBio Pharma, Inc.
Form
8-K
Report Period
2026-06-22
Date Filed
2026-06-26
Time Filed
08:30:33
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EXHIBIT 10.1
Filing on SEC Edgar